Clinical Trial Update: Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). [Phase 2]

View source ↗

Summary

This update reports completion of a Phase 2 study evaluating RWJ-333369 (Carsibamate) for the treatment of diabetic peripheral neuropathy, focusing on safety an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Mononeuropathy
• Diabetic Neuropathy
• Diabetic Peripheral Neuropathy
• Diabetic Polyneuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• RWJ-333369 (Carsibamate) (Carsibamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Diabetic Neuropathy, Painful, Diabetic Neuralgia | Phase 2 | Status: COMPLETED